Molecular basis of USP7 inhibition by selective small-molecule inhibitors

被引:329
|
作者
Turnbull, Andrew P. [1 ]
Ioannidis, Stephanos [2 ]
Krajewski, Wojciech W. [1 ]
Pinto-Fernandez, Adan [3 ]
Heride, Claire [4 ]
Martin, Agnes C. L. [5 ]
Tonkin, Louise M. [5 ]
Townsend, Elizabeth C. [2 ]
Buker, Shane M. [2 ,7 ]
Lancia, David R., Jr. [2 ]
Caravella, Justin A. [2 ]
Toms, Angela V. [2 ]
Charlton, Thomas M. [3 ,8 ]
Lahdenranta, Johanna [2 ]
Wilker, Erik [2 ]
Follows, Bruce C. [2 ]
Evans, Nicola J. [1 ,9 ]
Stead, Lucy [4 ]
Alli, Cristina [5 ]
Zarayskiy, Vladislav V. [2 ]
Talbot, Adam C. [2 ]
Buckmelter, Alexandre J. [2 ]
Wang, Minghua [2 ]
McKinnon, Crystal L. [2 ]
Saab, Fabienne [1 ]
McGouran, Joanna F. [3 ,10 ]
Century, Hannah [3 ,11 ]
Gersch, Malte [6 ]
Pittman, Marc S. [1 ,12 ]
Marshall, C. Gary [2 ]
Raynham, Tony M. [1 ,13 ]
Simcox, Mary [2 ,14 ]
Stewart, Lorna M. D. [1 ]
McLoughlin, Sheila B. [5 ]
Escobedo, Jaime A. [2 ]
Bair, Kenneth W. [2 ,15 ]
Dinsmore, Christopher J. [2 ]
Hammonds, Tim R. [1 ]
Kim, Sunkyu [2 ]
Urbe, Sylvie [4 ]
Clague, Michael J. [4 ]
Kessler, Benedikt M. [3 ]
Komander, David [6 ]
机构
[1] London Biosci Innovat Ctr, CRUK Therapeut Discovery Labs, London NW1 0NH, England
[2] FORMA Therapeut, Arsenal St, Watertown, MA 02472 USA
[3] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Roosevelt Dr, Oxford OX3 7FZ, England
[4] Univ Liverpool, Inst Translat Med, Cellular & Mol Physiol, Crown St, Liverpool L69 3BX, Merseyside, England
[5] CRUK Therapeut Discovery Labs, Jonas Webb Bldg,Babraham Res Campus, Cambridge CB22 3AT, England
[6] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England
[7] Goldfinch Bio, Cambridge, MA 02142 USA
[8] Univ Chicago, Dept Microbiol, CLSC 1117, Chicago, IL 60637 USA
[9] Kings Coll London, Dept Chem, London SE1 1DB, England
[10] Trinity Coll Dublin, Coll Green, Dublin 2, Ireland
[11] UCL, London WC1E 6BT, England
[12] CRUK Ctr Drug Dev, London EC1V 4AD, England
[13] Univ East London, Sch Hlth Sport & Biosci, Stratford Campus, London E15 4LZ, England
[14] Tarveda Therapeut, Watertown, MA 02472 USA
[15] Athelas Therapeut, Wellesley, MA 02432 USA
基金
英国工程与自然科学研究理事会; 英国惠康基金; 英国医学研究理事会; 欧洲研究理事会;
关键词
DEUBIQUITINATING ENZYME; UBIQUITIN SYSTEM; CATALYTIC DOMAIN; CANCER-THERAPY; GMP-SYNTHETASE; P53; PATHWAY; CELLS; ACTIVATION; PROTEASES;
D O I
10.1038/nature24451
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer. Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degradation of selected proteins, potentially including otherwise 'undruggable' targets. For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degradation of the oncogenic E3 ligase MDM2, and leads to re-activation of the tumour suppressor p53 in various cancers. Here we report that two compounds, FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells. Co-crystal structures reveal that both compounds target a dynamic pocket near the catalytic centre of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases. Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumour suppressor p21, and inhibition of tumour growth in mice.
引用
收藏
页码:481 / +
页数:21
相关论文
共 50 条
  • [31] Highlights in USP7 inhibitors for cancer treatment
    Oliveira, Rita I.
    Guedes, Romina A.
    Salvador, Jorge A. R.
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [32] Allosteric inhibitors hit USP7 hard
    Wei Zhang
    Sachdev S Sidhu
    Nature Chemical Biology, 2018, 14 : 110 - 111
  • [33] Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47
    Wu, Jian
    Weinstock, Joseph
    Cao, Ping
    Kingsbury, William D.
    Murphy, Randall B.
    McDermott, Jeffrey L.
    Kodrasov, Matthew P.
    Leach, Craig A.
    Kumar, Suresh
    Mattern, Michael R.
    Nicholson, Benjamin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [34] Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47
    Weinstock, Joseph
    Wu, Jian
    Cao, Ping
    Kingsbury, William D.
    McDermott, Jeffrey L.
    Kodrasov, Matthew P.
    McKelvey, Devin M.
    Kumar, K. G. Suresh
    Goldenberg, Seth J.
    Mattern, Michael R.
    Nicholson, Benjamin
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (10): : 789 - 792
  • [35] USP7: Structure, substrate specificity, and inhibition
    Pozhidaeva, Alexandra
    Bersonova, Irina
    DNA REPAIR, 2019, 76 : 30 - 39
  • [36] Discovery of a Potent and Selective Degrader for USP7
    Pei, Yuan
    Fu, Jingfeng
    Shi, Yunkai
    Zhang, Mengmeng
    Luo, Guanghao
    Luo, Xiaomin
    Song, Ning
    Mi, Tian
    Yang, Yaxi
    Li, Jia
    Zhou, Yubo
    Zhou, Bing
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 61 (33)
  • [37] SMALL-MOLECULE INHIBITORS bULKing up mTOR inhibition
    Goodwin, Jonathan M.
    Murphy, Leon O.
    NATURE CHEMICAL BIOLOGY, 2015, 11 (10) : 758 - 760
  • [38] Discovery and optimization of potent, selective, and bioavailable USP7 inhibitors to target tumor growth
    Leger, Paul
    Hu, Dennis
    Abraham, Betty
    Adsusmilli, Lavanya
    Biannic, Berenger
    Bradford, Delia
    Cutler, Gene
    Han, Xinping
    Jacobson, Scott
    Jorapur, Aparna
    Kassner, Paul
    Kaveri, Deepika
    Ketcham, John
    Kim, Andrea
    Maung, Jack
    McKinnell, Jenny
    Ohol, Yamini
    Okano, Akinori
    Peiser, Leanne
    Pookot, Deepa
    Rana, Payal
    Shah, Nick
    Shibuya, Grant
    Sun, Michael
    Suthram, Silpa
    Talay, Oezcan
    Young, Kyle
    Schwarz, Jacob
    Wustrow, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [39] Molecular mechanism for the substrate recognition of USP7
    Jingdong Cheng
    Ze Li
    Rui Gong
    Jian Fang
    Yi Yang
    Chang Sun
    Huirong Yang
    Yanhui Xu
    Protein & Cell, 2015, 6 (11) : 849 - 852
  • [40] Selective small-molecule inhibition of an RNA structural element
    John A. Howe
    Hao Wang
    Thierry O. Fischmann
    Carl J. Balibar
    Li Xiao
    Andrew M. Galgoci
    Juliana C. Malinverni
    Todd Mayhood
    Artjohn Villafania
    Ali Nahvi
    Nicholas Murgolo
    Christopher M. Barbieri
    Paul A. Mann
    Donna Carr
    Ellen Xia
    Paul Zuck
    Dan Riley
    Ronald E. Painter
    Scott S. Walker
    Brad Sherborne
    Reynalda de Jesus
    Weidong Pan
    Michael A. Plotkin
    Jin Wu
    Diane Rindgen
    John Cummings
    Charles G. Garlisi
    Rumin Zhang
    Payal R. Sheth
    Charles J. Gill
    Haifeng Tang
    Terry Roemer
    Nature, 2015, 526 : 672 - 677